Hope for patients with neuromyelitis optica spectrum disorders—from mechanisms to trials

SJ Pittock, A Zekeridou, BG Weinshenker - Nature Reviews Neurology, 2021 - nature.com
Neuromyelitis optica spectrum disorder (NMOSD) is a rare inflammatory CNS disease that
primarily manifests as relapsing episodes of severe optic neuritis and myelitis. Diagnosis of …

Diagnosis and treatment of NMO spectrum disorder and MOG-encephalomyelitis

N Borisow, M Mori, S Kuwabara, M Scheel… - Frontiers in …, 2018 - frontiersin.org
Neuromyelitis optica spectrum disorders (NMOSD) are autoantibody mediated chronic
inflammatory diseases. Serum antibodies (Abs) against the aquaporin-4 water channel lead …

Short delay to initiate plasma exchange is the strongest predictor of outcome in severe attacks of NMO spectrum disorders

M Bonnan, R Valentino, S Debeugny… - Journal of Neurology …, 2018 - jnnp.bmj.com
Introduction Severe attacks of neuromyelitis optica spectrum disorder (NMO-SD) are
improved by plasma exchange (PLEX) given as an adjunctive therapy. Initial studies failed …

Optic neuritis

AT Toosy, DF Mason, DH Miller - The Lancet Neurology, 2014 - thelancet.com
Acute optic neuritis is the most common optic neuropathy affecting young adults. Exciting
developments have occurred over the past decade in understanding of optic neuritis …

Neuromyelitis spectrum disorders

BG Weinshenker, DM Wingerchuk - Mayo Clinic Proceedings, 2017 - Elsevier
The understanding of neuromyelitis optica spectrum disorder (NMOSD) has evolved
substantially since its initial description over a century ago. The discovery in 2004 of a …

Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS)

C Trebst, S Jarius, A Berthele, F Paul, S Schippling… - Journal of …, 2014 - Springer
Neuromyelitis optica (NMO, Devic's syndrome), long considered a clinical variant of multiple
sclerosis, is now regarded as a distinct disease entity. Major progress has been made in the …

Sjogren's syndrome: An update on disease pathogenesis, clinical manifestations and treatment

FB Vivino, VY Bunya… - Clinical …, 2019 - pubmed.ncbi.nlm.nih.gov
Sjogren's syndrome: An update on disease pathogenesis, clinical manifestations and treatment
Sjogren's syndrome: An update on disease pathogenesis, clinical manifestations and treatment …

Neuromyelitis optica: clinical features, immunopathogenesis and treatment

S Jarius, B Wildemann, F Paul - Clinical & Experimental …, 2014 - academic.oup.com
Summary The term 'neuromyelitis optica'('Devic's syndrome', NMO) refers to a syndrome
characterized by optic neuritis and myelitis. In recent years, the condition has raised …

Treatment of neuromyelitis optica: state-of-the-art and emerging therapies

MC Papadopoulos, JL Bennett… - Nature Reviews …, 2014 - nature.com
Neuromyelitis optica (NMO) is an autoimmune disease of the CNS that is characterized by
inflammatory demyelinating lesions in the spinal cord and optic nerve, potentially leading to …

Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study

SJ Pittock, VA Lennon, A McKeon, J Mandrekar… - The Lancet …, 2013 - thelancet.com
Background Complement activation after binding of an IgG autoantibody to aquaporin 4
(AQP4) is thought to be a major determinant of CNS inflammation and astrocytic injury in …